PMD24 Economical Aspects of the Reimbursement of Extracorporeal Photopheresis (ECP) in Treatment of Patients With Graft-Versus-Host Disease (GvHD) After Allogeneic Hematopoietic Cell Transplantation (HCT) Who are Refractory to Steroid Treat ...
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.873
https://www.valueinhealthjournal.com/article/S1098-3015(12)02586-7/fulltext
Title :
PMD24 Economical Aspects of the Reimbursement of Extracorporeal Photopheresis (ECP) in Treatment of Patients With Graft-Versus-Host Disease (GvHD) After Allogeneic Hematopoietic Cell Transplantation (HCT) Who are Refractory to Steroid Treat ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02586-7&doi=10.1016/j.jval.2012.08.873
First page :
A349
Section Title :
Medical Device/Diagnostics
Open access? :
No
Section Order :
383